1-10-2024 9:24am

COVID-19 Activity Increases as Prevalence of JN.1 Variant Continues to Rise

Ypsilanti PressLLC Editor

News update on JN.1 COVID-19 variant can be found weekly here on Ypsilanti Press.

What CDC knows

The prevalence of the JN.1 variant continues to increase. JN.1 is now the most widely circulating variant of SARS-CoV-2, the virus that causes COVID-19, in the United States and around the world. Based on current data, available vaccines, tests, and treatments work against JN.1.

What CDC is doing

CDC, in collaboration with state and local public health departments, continues to track SARS-CoV-2 variants present in the United States, including JN.1. There is no evidence at this time that JN.1 causes more severe disease than other circulating variants.

Keep reading: COVID-19 Activity Increases as Prevalence of JN.1 Variant Continues to Rise

CDC Continues to Track the Growth of JN.1

December 22, 2023, 4:15 PM EDT

What CDC knows

CDC is tracking JN.1, one of many variants of SARS-CoV-2, the virus that causes COVID-19. As of December 23, 2023, JN.1 is projected to account for approximately 39-50% of circulating variants in the United States. The proportion of JN.1 continues to increase more rapidly than other variants. Based on laboratory data, existing vaccines, tests, and treatments work against JN.1. The JN.1 variant doesn’t change how we can protect ourselves and our communities. At this time, the spread of JN.1 does not appear to pose additional risks to public health beyond that of other recent variants. CDC is closely monitoring COVID-19 and will communicate if the situation changes.

What CDC is doing

CDC continues to track JN.1 and other emerging variants, in close collaboration with partners around the world. CDC is also closely tracking COVID-19 activity in the United States through multiple indicators.

Keep reading: CDC Continues to Track the Growth of JN.1